(1.26%) 5 127.79 points
(1.18%) 38 676 points
(1.99%) 16 156 points
(-1.23%) $77.98
(5.45%) $2.15
(0.03%) $2 310.20
(-0.10%) $26.80
(0.25%) $965.05
(-0.35%) $0.929
(-1.11%) $10.87
(-0.13%) $0.797
(0.37%) $91.47
5 days till quarter result
(bmo 2024-05-08)
Expected move: +/- 6.06%
-4.67% $ 1.430
Live Chart Being Loaded With Signals
Dyadic International, Inc., a biotechnology platform company, develops, produces, and sells enzymes and other proteins in the United States. The company utilizes its patented and proprietary C1 platform and other technologies to conduct research, development, and commercial activities for the development and manufacturing of human and animal vaccines and drugs, such as virus like particles and antigens, monoclonal antibodies, bi/tri-specific antibodies, fab antibody fragments, Fc-fusion proteins, biosimilars and/or biobetters, and other therapeutic enzymes and proteins...
Stats | |
---|---|
Volumen de hoy | 19 843.00 |
Volumen promedio | 22 179.00 |
Capitalización de mercado | 41.81M |
EPS | $0 ( 2024-03-28 ) |
Próxima fecha de ganancias | ( $-0.0700 ) 2024-05-08 |
Last Dividend | $0 ( N/A ) |
Next Dividend | $0 ( N/A ) |
P/E | -5.96 |
ATR14 | $0.0230 (1.61%) |
Date | Person | Action | Amount | type |
---|---|---|---|---|
2024-04-11 | Lucy Patrick K. | Buy | 13 125 | Stock Option |
2024-04-11 | Tarnok Michael P. | Sell | 13 125 | Stock Option |
2024-04-11 | Hazelton Joseph P | Buy | 20 000 | Stock Option |
2024-03-13 | Hazelton Joseph P | Buy | 41 720 | Common Stock |
2024-03-13 | Emalfarb Mark A | Buy | 124 454 | Common Stock |
INSIDER POWER |
---|
81.62 |
Last 99 transactions |
Buy: 3 507 936 | Sell: 1 014 811 |
Dyadic International Inc Correlación
10 Correlaciones Más Positivas | |
---|---|
RMRM | 0.973 |
TLGT | 0.916 |
APOP | 0.914 |
FCNCA | 0.9 |
SVAC | 0.897 |
TDAC | 0.895 |
XERS | 0.885 |
AQST | 0.885 |
BRKS | 0.885 |
BLRX | 0.884 |
10 Correlaciones Más Negativas | |
---|---|
MMAC | -0.936 |
NETE | -0.919 |
AMRB | -0.908 |
AEY | -0.897 |
BOCH | -0.893 |
TRUP | -0.89 |
PBHC | -0.887 |
EM | -0.884 |
MTP | -0.882 |
OBT | -0.878 |
Did You Know?
Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).
Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.
Dyadic International Inc Finanzas
Annual | 2023 |
Ingresos: | $2.90M |
Beneficio Bruto: | $922 957 (31.84 %) |
EPS: | $-0.240 |
FY | 2023 |
Ingresos: | $2.90M |
Beneficio Bruto: | $922 957 (31.84 %) |
EPS: | $-0.240 |
FY | 2022 |
Ingresos: | $2.93M |
Beneficio Bruto: | $807 110 (27.54 %) |
EPS: | $-0.330 |
FY | 2021 |
Ingresos: | $2.40M |
Beneficio Bruto: | $459 393 (19.11 %) |
EPS: | $-0.470 |
Financial Reports:
No articles found.
Dyadic International Inc
Dyadic International, Inc., a biotechnology platform company, develops, produces, and sells enzymes and other proteins in the United States. The company utilizes its patented and proprietary C1 platform and other technologies to conduct research, development, and commercial activities for the development and manufacturing of human and animal vaccines and drugs, such as virus like particles and antigens, monoclonal antibodies, bi/tri-specific antibodies, fab antibody fragments, Fc-fusion proteins, biosimilars and/or biobetters, and other therapeutic enzymes and proteins. It offers DYAI-100, SARS-CoV-2-RBD antigen vaccine candidate towards a first-in-human Phase 1 clinical trial, is to validate to serve as proof of concept for the development of next generation multivariant COVID-19 vaccine candidates. The company has a research and development agreement with VTT Technical Research Centre of Finland, Ltd.; strategic research services agreement with Biotechnology Developments for Industry in Pharmaceuticals, S.L.U.; and collaboration with Syngene International Limited. Dyadic International, Inc. was founded in 1979 and is headquartered in Jupiter, Florida.
Acerca de Señales en Vivo
Las señales en vivo presentadas en esta página ayudan a determinar cuándo COMPRAR o VENDER NA. Las señales tienen un retraso de más de 1 minuto; como todas las señales del mercado, existe la posibilidad de error o errores.
Las señales de trading en vivo no son definitivas y getagraph.com no asume ninguna responsabilidad por cualquier acción tomada sobre estas señales, como se describe en los Términos de Uso. Las señales se basan en una amplia gama de indicadores de análisis técnico